Proteinuria impairs podocyte regeneration by sequestering retinoic acid

Journal of the American Society of Nephrology

Volumn 24, Issue 11, 2013, Pages 1756-1768

  Peired, Anna ^a   Angelotti, Maria Lucia ^a   Ronconi, Elisa ^a   La Marca, Giancarlo ^b,c   Mazzinghi, Benedetta ^a   Sisti, Alessandro ^a   Lombardi, Duccio ^a   Giocaliere, Elisa ^c   Della Bona, Marialuisa ^c   Villanelli, Fabio ^c   Parente, Eliana ^a   Ballerini, Lara ^a   Sagrinati, Costanza ^a   Wanner, Nicola ^d,e   Huber, Tobias B ^d,e   Liapis, Helen ^f   Lazzeri, Elena ^a   Lasagni, Laura ^a   Romagnani, Paola ^a,c  

^a Transfer and High Education for the Development of De Novo Therapies (DENOTHE)   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

^d UNIVERSITY OF FREIBURG   (Germany)

^e UNIVERSITY OF FREIBURG   (Germany)

^f WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; DISULFIRAM; DOXORUBICIN; IMMUNOGLOBULIN G; RETINOIC ACID; TRANSFERRIN;

ALBUMINURIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; FEMALE; GLOMERULOSCLEROSIS; HUMAN; KIDNEY DISEASE; MORTALITY; MOUSE; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEINURIA;

EID: 84886677947     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2012090950     Document Type: Article

References (38)

1. Couser WG, Remuzzi G, Mendis S., Tonelli M: The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int 80: 1258-1270, 2011
2. Perico N, Benigni A, Remuzzi G: Present and future drug treatments for chronic kidney diseases: Evolving targets in renoprotection. Nat Rev Drug Discov 7: 936-953, 2008
3. Wiggins RC: The spectrum of podocytopathies: A unifying view of glomerular diseases. Kidney Int 71: 1205-1214, 2007 (Pubitemid 46884251)
4. D'Agati V.D., Kaskel FJ, Falk RJ: Focal segmental glomerulosclerosis. N Engl J Med 365: 2398-2411, 2011
5. Shankland SJ: The podocyte's response to injury: Role in proteinuria and glomerulosclerosis. Kidney Int 69: 2131-2147, 2006 (Pubitemid 43882099)
6. Remuzzi G, Benigni A, Remuzzi A: Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes. J Clin Invest 116: 288-296, 2006 (Pubitemid 43228342)
7. Gagliardini E, Corna D, Zoja C., Sangalli F, Carrara F, Rossi M., Conti S, Rottoli D, Longaretti L., Remuzzi A, Remuzzi G, Benigni A: Unlike each drug alone, lisinopril if combined with avosentan promotes regression of renal lesions in experimental diabetes. Am J Physiol Renal Physiol 297:F1448-F1456, 2009
8. Marinides GN, Groggel GC, Cohen A.H., Border WA: Enalapril and low protein reverse chronic puromycin aminonucleoside nephropathy. Kidney Int 37: 749-757, 1990 (Pubitemid 20056848)
9. Ikoma M, Kawamura T, Kakinuma Y., Fogo A, Ichikawa I: Cause of variable therapeutic efficiency of angiotensin converting enzyme inhibitor on glomerular lesions. Kidney Int 40: 195-202, 1991
10. Adamczak M, Gross ML, Krtil J, Koch A., Tyralla K, Amann K, Ritz E: Reversal of glomerulosclerosis after high-dose enalapril treatment in subtotally nephrectomized rats. J Am Soc Nephrol 14: 2833-2842, 2003 (Pubitemid 37305646)
11. Ruggenenti P, Perna A, Benini R., Bertani T, Zoccali C, Maggiore Q., Salvadori M, Remuzzi G: In chronic nephropathies prolonged ACE inhibition can induce remission: Dynamics of time-dependent changes in GFR. Investigators of the GISEN Group. Gruppo Italiano Studi Epidemiologici in Nefrologia. J Am Soc Nephrol 10: 997-1006, 1999 (Pubitemid 29203086)
12. Wilmer WA, Hebert LA, Lewis E.J., Rohde RD, Whittier F, Cattran D, Levey A.S., Lewis JB, Spitalewitz S, Blumenthal S, Bain RP: Remission of nephroticsyndrome in type 1 diabetes: Long-term follow-up of patients in the Captopril Study. Am J Kidney Dis 34: 308-314, 1999 (Pubitemid 29362097)
13. Remuzzi A, Gagliardini E, Sangalli F., Bonomelli M, Piccinelli M, Benigni A., Remuzzi G: ACE inhibition reduces glomerulosclerosis and regenerates glomerular tissue in a model of progressive renal disease. Kidney Int 69: 1124-1130, 2006
14. Romagnani P: Toward the identification of a "renopoietic system"? Stem Cells 27: 2247-2253, 2009
15. Ronconi E, Sagrinati C, Angelotti M.L., Lazzeri E., Mazzinghi B, Ballerini L, Parente E., Becherucci F, Gacci M, Carini M., Maggi E, Serio M, Vannelli G.B., Lasagni L., Romagnani S, Romagnani P: Regeneration of glomerular podocytes by human renal progenitors. J Am Soc Nephrol 20: 322-332, 2009
16. Appel D, Kershaw DB, Smeets B, Yuan G., Fuss A, Frye B, Elger M., Kriz W, Floege J, Moeller MJ: Recruitment of podocytes from glomerular parietal epithelial cells. J Am Soc Nephrol 20: 333-343, 2009
17. Lasagni L, Romagnani P: Glomerular epithelial stem cells: The good, the bad, and the ugly. J Am Soc Nephrol 21: 1612-1619, 2010
18. Mallipattu SK, Liu R, Zheng F., Narla G, Ma'ayan A, Dikman S, Jain MK, Saleem M, D'Agati V, Klotman P, Chuang PY, He JC: Kruppel-likefactor 15 (KLF15) is a key regulator of podocyte differentiation. J Biol Chem 287: 19122-19135, 2012
19. Hryciw DH, Pollock CA, Poronnik P: PKC-alpha-mediated remodeling of the actin cytoskeleton is involved in constitutive albumin uptake by proximal tubule cells. Am J Physiol Renal Physiol 288: F1227-F1235, 2005 (Pubitemid 40677093)
20. Gudas LJ, Wagner JA: Retinoids regulate stem cell differentiation. J Cell Physiol 226: 322-330, 2011
21. Shima Y, Iwano M, Yoshizaki K., Tanaka T, Kawase I, Nishimoto N: Alltrans-retinoic acid inhibits the development of mesangial proliferative glomerulonephritis in interleukin-6 transgenic mice. Nephron, Exp Nephrol 100: e54-e62, 2005
22. Vaughan MR, Pippin JW, Griffin S.V., Krofft R., Fleet M, Haseley L, Shankland SJ: ATRA induces podocyte differentiation and alters nephrin and podocin expression in vitro and in vivo. Kidney Int 68: 133-144, 2005 (Pubitemid 43181370)
23. Wagner J, Dechow C, Morath C., Lehrke I, Amann K, Waldherr R., Floege J, Ritz E: Retinoic acid reduces glomerular injury in a rat model of glomerular damage. J Am Soc Nephrol 11: 1479-1487, 2000 (Pubitemid 30483464)
24. Han SY, So GA, Jee Y.H., Han KH, Kang YS, Kim HK, Kang S.W., Han DS, Han JY, Cha DR: Effect of retinoic acid in experimental diabetic nephropathy. Immunol Cell Biol 82: 568-576, 2004
25. Ratnam KK, Feng X, Chuang P.Y., Verma V., Lu TC, Wang J, Jin Y, Farias E.F., Napoli JL, Chen N, Kaufman L, Takano T., D'Agati VD, Klotman PE, He JC: Role of the retinoic acid receptor - a in HIV-associated nephropathy. Kidney Int 79: 624-634, 2011
26. Zhang J, Pippin JW, Vaughan M.R., Krofft RD, Taniguchi Y, Romagnani P, Nelson P.J., Liu ZH, Shankland SJ: Retinoids augment the expression of podocyte proteins by glomerular parietal epithelial cells in experimental glomerular disease. Nephron Exp Nephrol 121: e23-e37, 2012
27. Kinoshita K, Kishimoto K, Shimazu H., Nozaki Y, Sugiyama M, Ikoma S., Funauchi M: Successful treatment with retinoids in patients with lupus nephritis. Am J Kidney Dis 55: 344-347, 2010
28. Niederreither K, Dollé P: Retinoic acid in development: Towards an integrated view. Nat Rev Genet 9: 541-553, 2008 (Pubitemid 351861538)
29. Smeets B, Angelotti ML, Rizzo P, Dijkman H., Lazzeri E, Mooren F, Ballerini L., Parente E, Sagrinati C, Mazzinghi B., Ronconi E, Becherucci F, Benigni A., Steenbergen E, Lasagni L, Remuzzi G., Wetzels J, Romagnani P: Renal progenitor cells contribute to hyperplastic glomerular lesions of different types of podocytopathies and in crescentic glomerulonephritis. J Am Soc Nephrol 20: 2593-2603, 2009
30. Smeets B, Kuppe C, Sicking E.M., Fuss A., Jirak P, van Kuppevelt TH, Endlich K, Wetzels JF, Gröne HJ, Floege J., Moeller MJ: Parietal epithelial cells participate in the formation of sclerotic lesions in focal segmental glomerulosclerosis. J Am Soc Nephrol 22: 1262-1274, 2011
31. Okamura K, Dummer P, Kopp J., Qiu L, Levi M, Faubel S., Blaine J: Endocytosis of albumin by podocytes elicits an inflammatory response and induces apoptotic cell death. PLoS ONE 8: e54817, 2013 10.1371/journal.pone.0054817
32. Angelotti ML, Ronconi E, Ballerini L., Peired A, Mazzinghi B, Sagrinati C., Parente E, Gacci M, Carini M., Rotondi M, Fogo AB, Lazzeri E, Lasagni L., Romagnani P: Characterization of renal progenitors committed toward tubular lineage and their regenerative potential in renal tubular injury. Stem Cells 30: 1714-1725, 2012
33. Hu B, Gadegbeku C, Lipkowitz M.S., Rostand S., Lewis J, Wright JT, Appel L.J., Greene T., Gassman J, Astor BC; African-American Study of Kidney Disease and Hypertension Group: Kidney function can improve in patients with hypertensive CKD. J Am Soc Nephrol 23: 706-713, 2012
34. Macconi D, Sangalli F, Bonomelli M., Conti S, Condorelli L, Gagliardini E., Remuzzi G, Remuzzi A: Podocyte repopulation contributes to regression of glomerular injury induced by ACE inhibition. Am J Pathol 174: 797-807, 2009
35. Benigni A, Morigi M, Rizzo P., Gagliardini E, Rota C, Abbate M., Ghezzi S, Remuzzi A, Remuzzi G: Inhibiting ACE promotes renal repair by limiting progenitor cell proliferation and restoring the glomerular architecture. Am J Pathol 179: 628-638, 2011
36. Deegens JK, Wetzels JF: Fractional excretion of high- and low-molecular weight proteins and outcome in primary focal segmental glomerulosclerosis. Clin Nephrol 68: 201-208, 2007 (Pubitemid 47527439)
37. Remuzzi G, Bertani T: Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules? Kidney Int 38: 384-394, 1990 (Pubitemid 20258739)
38. Zheng Z, Pavlidis P, Chua S., D'Agati VD, Gharavi AG: An ancestral haplotype defines susceptibility to doxorubicin nephropathy in the laboratory mouse. J Am Soc Nephrol 17: 1796-1800, 2006 (Pubitemid 44036163)